Senior Vice President, Operations
Chris joined Polaris Pharmaceuticals in 2005. During his time at Polaris he has held management positions in Manufacturing, Quality Assurance, and Quality Control. He helped transfer the ADI-PEG 20 manufacturing process to the Vacaville site and has been involved with the manufacture of all clinical drug product batches at that site. Prior to joining Polaris, he worked for a small biotech company where he designed and supervised studies that led to the regulatory approval of a novel animal vaccine. Chris received his Ph.D. degree in Physiology with an emphasis in Endocrinology from the University of California, Davis.